Skip to Content
Find More Like This
Return to Search

Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG

United States Patent

6,462,084
October 8, 2002
View the Complete Patent at the US Patent & Trademark Office
Brookhaven National Laboratory - Visit the Office of Technology Commercialization and Partnerships Website
The present invention relates to the use of gamma vinyl-GABA (GVG) to treat obsessive-compulsive disorder (OCD) and OCD-related disorders, and to reduce or eliminate behaviors associated with obsessive-compulsive disorder (OCD) and OCD-related disorders.
Dewey; Stephen L. (Manorville, NY), Brodie; Jonathan D. (Cos Cob, CT), Ashby, Jr.; Charles R. (Miller Place, NY)
Brookhaven Science Associates, LLC (Upton, NY)
09/ 853,392
May 14, 2001
This invention was made with Government support under contract number DE-AC02-98CH10886, awarded by the U.S. Department of Energy. The Government has certain rights in the invention.